Literature DB >> 11304024

The prevalence of migraine in women aged 40-74 years: a population-based study.

P Mattsson1, K Svärdsudd, P O Lundberg, C E Westerberg.   

Abstract

The objective of this study was to investigate the age-dependence of the prevalence and characteristics of migraine headache and migraine visual aura. A neurologist interviewed 728 women attending a mammography screening programme. International Headache Society (IHS) criteria were used. The lifetime prevalence of migraine headache was 31.5% and the 1-year prevalence 18.0%. The magnitude of the decline of the prevalence of active (one or more attacks in the previous year) migraine headache was estimated to 50% per decade. The prevalence of active migraine visual aura was 3.8%. This did not vary by age. Except for the pain intensity and the presence of nausea, other characteristics and concomitant symptoms did not change with age. Active migraine headache and migraine visual aura in middle-aged and older women are common and modified differently by age. We suggest that the decline of prevalence of active migraine headache with age is caused by a decrease in pain intensity.

Entities:  

Mesh:

Year:  2000        PMID: 11304024     DOI: 10.1046/j.1468-2982.2000.00133.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  11 in total

1.  Migraine with aura in patients over 50 years of age: the Marseille’s registry.

Authors:  Anne Donnet; Clément Daniel; Loïc Milandre; Julie Berbis; Pascal Auquier
Journal:  J Neurol       Date:  2012-09       Impact factor: 4.849

Review 2.  Practical considerations for the treatment of elderly patients with migraine.

Authors:  Paola Sarchielli; Maria Luisa Mancini; Paolo Calabresi
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

3.  Has the prevalence of migraine and tension-type headache changed over a 12-year period? A Danish population survey.

Authors:  Ann Christine Lyngberg; Birthe K Rasmussen; Torben Jørgensen; Rigmor Jensen
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

4.  Triptan safety during pregnancy: a Norwegian population registry study.

Authors:  Kateřina Nezvalová-Henriksen; Olav Spigset; Hedvig Nordeng
Journal:  Eur J Epidemiol       Date:  2013-07-25       Impact factor: 8.082

5.  Self-reported menstrual migraine in the general population.

Authors:  Kjersti Grøtta Vetvik; E Anne MacGregor; Christofer Lundqvist; Michael Bjørn Russell
Journal:  J Headache Pain       Date:  2010-02-26       Impact factor: 7.277

Review 6.  Traditional and Novel Migraine Therapy in the Aging Population.

Authors:  Shema Mathew; Jessica Ailani
Journal:  Curr Pain Headache Rep       Date:  2019-05-11

Review 7.  Headache in the elderly: primary forms.

Authors:  Maria Clara Tonini; Gennaro Bussone
Journal:  Neurol Sci       Date:  2010-06       Impact factor: 3.307

Review 8.  Prevalence of headache in Europe: a review for the Eurolight project.

Authors:  Lars Jacob Stovner; Colette Andree
Journal:  J Headache Pain       Date:  2010-05-16       Impact factor: 7.277

9.  A cross-sectional population-based survey of migraine and headache in 21,177 Norwegians: the Akershus sleep apnea project.

Authors:  Michael Bjørn Russell; Håvard Anton Kristiansen; Jūrate Saltyte-Benth; Kari Jorunn Kvaerner
Journal:  J Headache Pain       Date:  2008-10-11       Impact factor: 7.277

10.  Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials.

Authors:  Virginia L Stauffer; Ira Turner; Phebe Kemmer; William Kielbasa; Kathleen Day; Martha Port; Tonya Quinlan; Angelo Camporeale
Journal:  J Headache Pain       Date:  2020-06-23       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.